Alonso Arguelles
Sr. Advisor Chemistry at Eli Lilly
Hailing from Lima, Peru, Alonso joined the Synthetic Molecule Design and Development (SMDD) organization at Lilly in 2019 after completing his PhD studies in Organic Chemistry at the University of Michigan with Prof. Pavel Nagorny and Prof. Paul Zimmerman. During his graduate studies he worked on the development and application of novel acetal containing ligands for asymmetric transition metal catalysis, as well as quantum-chemical mechanistic investigations of phosphoric acid-catalyzed acetalizations. Currently a Sr. Advisor-Chemistry, Alonso has worked on the process development and optimization for several projects spanning from early development to post-approval modifications, including peptide assets as well as anti-cancer small-molecules such as selpercatinib, pirtobrutinib, imlunestrant. In parallel, Alonso leads the SMDD Data-Rich Experimentation Team and is highly enthusiastic about cultivating a data-rich and automation-centric culture in SMDD